Piramal Fund Mgmt okays Rs 1,020 cr investment in 2 projects under lease rental scheme
Piramal Enterprises' financial services division, Piramal Fund Management (PFM), has sanctioned two investments worth Rs 1,020 crore under its flexible lease rental discounting (LRD) scheme.The firm... Intimation of Schedule of Analyst / Institutional Investor Meetings
Piramal Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".
Piramal Enterprises Q3 profit up 32% to Rs404.08 crore
The company's consolidated total income from operations rose to Rs2,341.74 crore for the quarter under consideration as against Rs1,786.01 crore for the same period year ago Announces Q3 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Results Presentation for the Quarter ended December 31, 2016
Piramal Enterprises Ltd has announced the following results for the quarter ended December 31, 2016 The Unaudited Standalone results for the Quarter ended December 31, 2016:The Company has posted a net profit of Rs. 601.60 million for the quarter ended December 31, 2016 where as the same was at Rs. 2716.70 million for the quarter ended December 31, 2015. Total Income is Rs. 7729.20 million for the quarter ended December 31, 2016 where... Transcript of Conference Call with Investors/Analysts
Piramal Enterprises Ltd has informed BSE regarding "Transcript of Conference Call with Investors/Analysts". Q3 results on Feb 13, 2017
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2017, to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2016 (Q3).In this regard, the Trading Window for dealing in the securities of the Company will remain closed from February 07, 2017 to February 15, 2017 (both... Presentation to the Analyst / Institutional Investor
Piramal Enterprises Ltd has informed BSE regarding "Presentation to the Analyst / Institutional Investor".
Piramal Enterprises buys drug portfolio from UK firm for Rs1,160 crore
Chairman Ajay Piramal says the acquisition is a prelude to Piramal Enterprises's plans to spin off and list its financial services unit and pharma business Piramal Enterprises To Demerge Healthcare, Financial Services Businesses
Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010. Intimation of Conference Call with Investors/ Analysts
Piramal Enterprises Ltd has informed BSE regarding "Intimation of Conference Call with Investors/ Analysts".